Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Fibroblast growth factor 21 (FGF21) , an endocrine hormone in the FGF family, plays a key role in regulating metabolic homeostasis and has become a therapeutic target for metabolic diseases including type 2 diabetes. FGF21 acts through a receptor complex consisting of an FGF receptor (FGFR) and a co-receptor β-Klotho. 39F7, a high-affinity monoclonal antibody (mAb) against beta-Klotho, mimics the function of FGF21. In addition, the identification of 39F7 focused on β-Klotho's Trp-295 in a non-competitive manner with FGF21. In vitro characterization showed that 39F7 was specific for β-Klotho/FGFR1c activation. In addition, 39F7 can act by promoting receptor/co-receptor dimers.